Tempest Therapeutics
IPOTargeted and Immune-Mediated Cancer Therapies
Public · Brisbane, United States · Founded 2011 · $85.0M raised
- Headquarters
- Brisbane, California
- Employees
- 11–50
- Founded
- 2011
- Business Model
- B2B
- Website
- tempesttx.com
- Total Funding
- $85.0M
- Last Round
- $15.0M Private EquityApr 2022
- Rounds
- 2
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Tempest Therapeutics is a clinical-stage biotechnology company focused on pioneering a pipeline of next generation in vivo CAR-T cell therapies for autoimmune and oncology indications. Through a dual-target CD19/BCMA CAR structure and a proprietary CD7-targeted mRNA lipid nanoparticle CAR-T delivery platform, the company is expanding next-generation cell therapy with broader T-cell reach, better intracellular delivery, and scalable repeat dosing. TPST-4003, its lead in vivo CAR-T candidate, is planned for investigator-initiated trials in myasthenia gravis and multiple sclerosis.
Summary
Tempest Therapeutics is a Biotech company based in Brisbane, United States, founded in 2011. It has raised $85.0M in total across 2 rounds, most recently a $15.0M Private Equity round in Apr 2022. Investors include Versant Ventures, EcoR1 Capital and F-Prime Capital.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2022
Sign up to see all 2 events
Funding: Series B through Private Equity. Amounts, valuations, and investors where available.
Investors
Similar Companies
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/tempest-therapeutics"><img src="https://indexed.vc/api/badge/company/tempest-therapeutics" alt="Tempest Therapeutics on Indexed.vc" width="260" height="76" /></a>